Cargando…

Curcumin restores sensitivity to retinoic acid in triple negative breast cancer cells

BACKGROUND: A major obstacle in the use of retinoid therapy in cancer is the resistance to this agent in tumors. Retinoic acid facilitates the growth of mammary carcinoma cells which express high levels of fatty acid-binding protein 5 (FABP5). This protein delivers retinoic acid to peroxisome prolif...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thulasiraman, Padmamalini, McAndrews, Daniel J, Mohiudddin, Imran Q
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4192446/ https://www.ncbi.nlm.nih.gov/pubmed/25260874 http://dx.doi.org/10.1186/1471-2407-14-724

Ejemplares similares

Activation of the CRABPII/RAR pathway by curcumin induces retinoic acid mediated apoptosis in retinoic acid resistant breast cancer cells
por: Thulasiraman, Padmamalini, et al.
Publicado: (2017)

DNA Methylation Predicts the Response of Triple-Negative Breast Cancers to All-Trans Retinoic Acid
por: Coyle, Krysta Mila, et al.
Publicado: (2018)

Retinoic Acid Sensitivity of Triple-Negative Breast Cancer Cells Characterized by Constitutive Activation of the notch1 Pathway: The Role of Rarβ
por: Paroni, Gabriela, et al.
Publicado: (2020)

Involvement of Fatty Acid Binding Protein 5 and PPARβ/δ in Prostate Cancer Cell Growth
por: Morgan, Elwin, et al.
Publicado: (2010)

Curcumin inhibits the growth of triple‐negative breast cancer cells by silencing EZH2 and restoring DLC1 expression
por: Zhou, Xueliang, et al.
Publicado: (2020)

ABCG2 transporter inhibitor restores the sensitivity of triple negative breast cancer cells to aminolevulinic acid-mediated photodynamic therapy
por: Palasuberniam, Pratheeba, et al.
Publicado: (2015)

Curcumin–Copper Complex Nanoparticles for the Management of Triple-Negative Breast Cancer
por: Greish, Khaled, et al.
Publicado: (2018)

Regulation of Mucin 1 and multidrug resistance protein 1 by honokiol enhances the efficacy of doxorubicin-mediated growth suppression in mammary carcinoma cells
por: Thulasiraman, Padmamalini, et al.
Publicado: (2016)

Cisplatin-resistant triple-negative breast cancer subtypes: multiple mechanisms of resistance
por: Hill, David P., et al.
Publicado: (2019)

CCN5/WISP-2 restores ER-∝ in normal and neoplastic breast cells and sensitizes triple negative breast cancer cells to tamoxifen
por: Sarkar, S, et al.
Publicado: (2017)

The efficacy of betulinic acid in triple-negative breast cancer
por: Weber, Daniel, et al.
Publicado: (2014)

Curcumin and Resveratrol as Promising Natural Remedies with Nanomedicine Approach for the Effective Treatment of Triple Negative Breast Cancer
por: Shindikar, Amol, et al.
Publicado: (2016)

Synthesis of Curcumin Derivatives and Analysis of Their Antitumor Effects in Triple Negative Breast Cancer (TNBC) Cell Lines
por: Bonaccorsi, Paola Maria, et al.
Publicado: (2019)

Self-Assembly Engineering Nanodrugs Composed of Paclitaxel and Curcumin for the Combined Treatment of Triple Negative Breast Cancer
por: Zuo, Shuting, et al.
Publicado: (2021)

Genomic Index of Sensitivity to Chemotherapy for Triple Negative Breast Cancer
por: C, Ahammad Sameer, et al.
Publicado: (2023)

Retinoic acid reduces migration of human breast cancer cells: role of retinoic acid receptor beta
por: Flamini, Marina Inés, et al.
Publicado: (2014)

Restoration of p53 activity via intracellular protein delivery sensitizes triple negative breast cancer to anti-PD-1 immunotherapy
por: Yang, Zaofeng, et al.
Publicado: (2022)

Synergistic Antitumorigenic Activity of Calcitriol with Curcumin or Resveratrol is Mediated by Angiogenesis Inhibition in Triple Negative Breast Cancer Xenografts
por: García-Quiroz, Janice, et al.
Publicado: (2019)

Endothelium-Dependent Induction of Vasculogenic Mimicry in Human Triple-Negative Breast Cancer Cells Is Inhibited by Calcitriol and Curcumin
por: Morales-Guadarrama, Gabriela, et al.
Publicado: (2022)

Epigenetic restoration and activation of ERβ: an inspiring approach for treatment of triple-negative breast cancer
por: Salahuddin, Ahmad, et al.
Publicado: (2022)

CLDN1 Sensitizes Triple-Negative Breast Cancer Cells to Chemotherapy
por: Lemesle, Marine, et al.
Publicado: (2022)

Inhibition of retinoic acid receptor α phosphorylation represses the progression of triple-negative breast cancer via transactivating miR-3074-5p to target DHRS3
por: Lou, Siyue, et al.
Publicado: (2021)

Fatty acid synthetase expression in triple-negative breast cancer
por: Park, Jin Hee, et al.
Publicado: (2022)

Modulation of the BRCA1 Protein and Induction of Apoptosis in Triple Negative Breast Cancer Cell Lines by the Polyphenolic Compound Curcumin
por: Rowe, Danica L., et al.
Publicado: (2009)

Dominant negative retinoic acid receptor initiates tumor formation in mice
por: Kupumbati, Tara S, et al.
Publicado: (2006)

PLZF is a negative regulator of retinoic acid receptor transcriptional activity
por: Martin, Perrine J, et al.
Publicado: (2003)

EMBO Retinoids 2011: mechanisms, biology and pathology of signaling by retinoic acid and retinoic acid receptors
por: McKenna, Neil J.
Publicado: (2012)

All-trans retinoic acids induce differentiation and sensitize a radioresistant breast cancer cells to chemotherapy
por: Yan, Yunwen, et al.
Publicado: (2016)

PRIMA-1(MET) Does Not Restore Vitamin D Sensitivity to MDA-MB-231 and MDA-MB-468 Triple-Negative Breast Cancer Cells
por: Kotob, Shadi N., et al.
Publicado: (2023)

Triple-Negative Breast Cancer
por: Chu, Quyen D., et al.
Publicado: (2012)

Triple-negative breast cancer
por: Chacón, Reinaldo D, et al.
Publicado: (2010)

Silencing of CXCR4 sensitizes triple-negative breast cancer cells to cisplatin
por: Liang, Sixian, et al.
Publicado: (2014)

Impact of COVID-19 Pandemic on Ovarian Cancer Management: Adjusting to the New Normal
por: Jacome, Lizbeth Soto, et al.
Publicado: (2021)

Loss of growth inhibitory effects of retinoic acid in human breast cancer cells following long-term exposure to retinoic acid
por: Stephen, R, et al.
Publicado: (2000)

Retinoic Acid Embryopathy
por: Mondal, Dipankar, et al.
Publicado: (2017)

Curcumin-Loaded Solid Lipid Nanoparticles Bypass P-Glycoprotein Mediated Doxorubicin Resistance in Triple Negative Breast Cancer Cells
por: Fathy Abd-Ellatef, Gamal-Eldein, et al.
Publicado: (2020)

Gambogic acid increases the sensitivity to paclitaxel in drug-resistant triple-negative breast cancer via the SHH signaling pathway
por: Wang, Yonghui, et al.
Publicado: (2019)

COVID-19: Endogenous Retinoic Acid Theory and Retinoic Acid Depletion Syndrome
por: Sarohan, Aziz Rodan
Publicado: (2020)

Dipalmitoylphosphatidic acid inhibits tumor growth in triple-negative breast cancer
por: Zhang, Qian-Qian, et al.
Publicado: (2017)

Vitamin C sensitizes triple negative breast cancer to PI3K inhibition therapy
por: Mustafi, Sushmita, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bld7lrgta2ldsr41hru0oi8fi7